Literature DB >> 2837482

Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines.

D J Hilton1, N A Nicola, N M Gough, D Metcalf.   

Abstract

The use of different myeloid leukemic cell lines (WEHI-3B D+ and M1) and different sources of factors has led to discrepancies concerning the identity of factors capable of inducing differentiation in leukemic cells. We have biochemically fractionated medium conditioned by one such source (Krebs II ascites cells) and assayed fractions for their bone marrow colony-stimulating activity as well as their differentiation-inducing activity for WEHI-3B D+ and M1 cells. This resulted in the resolution of four distinct molecular species with differentiation-inducing activity. One activity was purified to homogeneity and shown by a variety of biochemical, biological, and receptor-binding criteria to be authentic granulocyte colony-stimulating factor (G-CSF). A second activity was identified as granulocyte-macrophage colony-stimulating factor (GM-CSF). Two other activities termed LIF-A and LIF-B (leukemia inhibitory factor) were shown to probably be different glycosylation variants of the same protein and one of these (LIF-A) was purified 12,000-fold to homogeneity. G-CSF induced differentiation in both WEHI-3B D+ and at higher concentrations M1 cells while GM-CSF weakly induced differentiation in WEHI-3B D+ cells. LIF-A had no colony-stimulating activity and induced differentiation in and inhibited the proliferation of only M1 cells. Each factor bound to a unique cell surface receptor with no evidence of direct cross-reactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837482

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

2.  Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation.

Authors:  H Bhatt; L J Brunet; C L Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Continuous cultures of macrophages derived from the 8-day epiblast of the pig.

Authors:  N C Talbot; M Worku; M J Paape; P Grier; C E Rexroad; V G Pursel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-10       Impact factor: 2.416

Review 4.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

Review 5.  Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor.

Authors:  Hiroyuki Hirai; Peter Karian; Nobuaki Kikyo
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

6.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.

Authors:  T M Rose; A G Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

7.  Resonance assignments, secondary structure and topology of leukaemia inhibitory factor in solution.

Authors:  M G Hinds; T Maurer; J G Zhang; N A Nicola; R S Norton
Journal:  J Biomol NMR       Date:  1997-02       Impact factor: 2.835

8.  Complete sequence of murine myeloid leukaemia inhibitory factor (LIF).

Authors:  D P Gearing; J A King; N M Gough
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

9.  The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation.

Authors:  T Tanigawa; N Elwood; D Metcalf; D Cary; E DeLuca; N A Nicola; C G Begley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

10.  Induction of cytokine expression by leukemia inhibitory factor.

Authors:  P M Villiger; Y Geng; M Lotz
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.